| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aging and the management of cancer pain
|
Gagliese, L.
|
|
|
20 |
10 |
p. 1752
|
artikel
|
| 2 |
Antitumoral effect of the bisphosphonate zoledronic acid against visceral metastases in an adrenocortical cancer patient
|
Boudou-Rouquette, P.
|
|
|
20 |
10 |
p. 1747
|
artikel
|
| 3 |
Breast cancer in young women (YBC): prevalence of BRCA1/2 mutations and risk of secondary malignancies across diverse racial groups
|
Haffty, B.G.
|
|
|
20 |
10 |
p. 1653-1659
|
artikel
|
| 4 |
Cancer and thrombosis: implications of published guidelines for clinical practice
|
Khorana, A.A.
|
|
|
20 |
10 |
p. 1619-1630
|
artikel
|
| 5 |
Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie
|
Lorenzen, S.
|
|
|
20 |
10 |
p. 1667-1673
|
artikel
|
| 6 |
Combination of sunitinib, cetuximab and irradiation in an orthotopic head and neck cancer model
|
Bozec, A.
|
|
|
20 |
10 |
p. 1703-1707
|
artikel
|
| 7 |
Cytokines and angiogenic factors in patients with metastatic renal cell carcinoma treated with interferon-α: association of pretreatment serum levels with survival
|
Montero, A.J.
|
|
|
20 |
10 |
p. 1682-1687
|
artikel
|
| 8 |
Dietary glycemic load and hepatocellular carcinoma with or without chronic hepatitis infection
|
Rossi, M.
|
|
|
20 |
10 |
p. 1736-1740
|
artikel
|
| 9 |
Discussion about switch strategy in the adjuvant hormonal therapy of breast cancer: psychological aspects of physician–patient communication
|
Costantini, A.
|
|
|
20 |
10 |
p. 1647-1652
|
artikel
|
| 10 |
Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer?
|
Hietanen, P.
|
|
|
20 |
10 |
p. 1749-1751
|
artikel
|
| 11 |
Editorial board
|
|
|
|
20 |
10 |
p. ii-iii
|
artikel
|
| 12 |
Efficacy of everolimus (RAD001) in patients with advanced NSCLC previously treated with chemotherapy alone or with chemotherapy and EGFR inhibitors
|
Soria, J.-C.
|
|
|
20 |
10 |
p. 1674-1681
|
artikel
|
| 13 |
Empirically derived psychosocial states among adolescents diagnosed with cancer during the acute and extended phase of survival
|
Mattsson, E.
|
|
|
20 |
10 |
p. 1722-1727
|
artikel
|
| 14 |
Gemcitabine and pemetrexed combination: the key role of the sequence of drugs administration
|
De Pas, T.M.
|
|
|
20 |
10 |
p. 1747-1748
|
artikel
|
| 15 |
Glycemic load in relation to hepatocellular carcinoma among patients with chronic hepatitis infection
|
Lagiou, P.
|
|
|
20 |
10 |
p. 1741-1745
|
artikel
|
| 16 |
Health-related quality of life in disease-free survivors of breast cancer with the general population
|
Ahn, S.H.
|
|
|
20 |
10 |
p. 1753-1754
|
artikel
|
| 17 |
Increased quantity of tumor-infiltrating FOXP3-positive regulatory T cells is an independent predictor for improved clinical outcome in extranodal NK/T-cell lymphoma
|
Kim, W.Y.
|
|
|
20 |
10 |
p. 1688-1696
|
artikel
|
| 18 |
in this issue
|
|
|
|
20 |
10 |
p. 1613
|
artikel
|
| 19 |
Medical oncology patients’ preferences with regard to health care: development of a patient-driven questionnaire
|
Wessels, H.
|
|
|
20 |
10 |
p. 1708-1713
|
artikel
|
| 20 |
Metachronous gastric cancer following complete remission of gastric MALT lymphoma
|
Ono, S.
|
|
|
20 |
10 |
p. 1748-1749
|
artikel
|
| 21 |
Modeling of treatment response to erythropoiesis-stimulating agents as a function of center- and patient-related variables: results from the Anemia Cancer Treatment (ACT) study
|
Aapro, M.
|
|
|
20 |
10 |
p. 1714-1721
|
artikel
|
| 22 |
MTHFR polymorphisms and 5-FU-based adjuvant chemotherapy in colorectal cancer
|
Afzal, S.
|
|
|
20 |
10 |
p. 1660-1666
|
artikel
|
| 23 |
Natural history and clinical outcome of differentiated thyroid carcinoma: a retrospective analysis of 1503 patients treated at a single institution
|
Sciuto, R.
|
|
|
20 |
10 |
p. 1728-1735
|
artikel
|
| 24 |
Quality assurance for radical hysterectomy for cervical cancer: the view of the European Organization for Research and Treatment of Cancer—Gynecological Cancer Group (EORTC-GCG)
|
Verleye, L.
|
|
|
20 |
10 |
p. 1631-1638
|
artikel
|
| 25 |
Reply to Does the expert panel at the St Gallen meeting provide an unbiased opinion about the management of women with early breast cancer?
|
Coates, A.S.
|
|
|
20 |
10 |
p. 1751-1752
|
artikel
|
| 26 |
Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer
|
Linderholm, B.K.
|
|
|
20 |
10 |
p. 1639-1646
|
artikel
|
| 27 |
Table of Contents
|
|
|
|
20 |
10 |
p. iv-v
|
artikel
|
| 28 |
The role of VEGF in triple-negative breast cancer: where do we go from here?
|
Dent, S.F.
|
|
|
20 |
10 |
p. 1615-1617
|
artikel
|
| 29 |
Validation, revision and extension of the Follicular Lymphoma International Prognostic Index (FLIPI) in a population-based setting
|
van de Schans, S.A.M.
|
|
|
20 |
10 |
p. 1697-1702
|
artikel
|
Tijdschrift beschrijving